Considering the disruptions imposed by lockdowns and social distancing recommendations, coupled with overwhelmed healthcare systems, researchers worldwide have been exploring drug repositioning strategies for treating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Matéria original


Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity


Potent and Selective Covalent Inhibitors of the Papain-like Protease from SARS-CoV-2